Companies Reporting Before The Bell
• Eve Holding (NYSE:EVEX) is likely to report earnings for its third quarter.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Alnylam Pharmaceuticals' updates on HELIOS-B Phase 3 study and FDA clearance for ALN-APP Phase 1 study. Fiscal year 2024 guidance of $1.4 billion–$1.5 billion in combined net product revenues.